Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 12:39:e056.
doi: 10.1590/1807-3107bor-2025.vol39.056. eCollection 2025.

Cytopathological quantification of NORs using artificial intelligence to oral cancer screening

Affiliations

Cytopathological quantification of NORs using artificial intelligence to oral cancer screening

Tatiana Wannmacher Lepper et al. Braz Oral Res. .

Abstract

Oral squamous cell carcinoma (OSCC) remains the most prevalent neoplasm of the head and neck. In recent decades, the incidence and prevalence of OSCC have not significantly changed, highlighting the critical need to develop and implement new risk assessment measures. The present study aimed to define argyrophilic proteins of the nucleolar organizer region (AgNOR) cut-off risk points by oral exfoliative cytological smears comparing specialized humans with a convolutional neural network (CNN) system AgNOR Slide-Image Examiner. This study included four experimental groups: control, exposure to carcinogens (alcohol and tobacco), oral potentially malignant disorders, and OSCC. In the first phase, 50 cells were used for AgNOR quantification. In the second phase, AgNOR quantification was established in an automated manner using an AgNOR System - Slide Examiner (captured - bounding-boxed - CNN analysis). In phase 1, the cut-off point for considering a smear as suspicious was established at 3.69 AgNORs/nucleus with sensitivity of 86%, specificity of 93%, and accuracy of 90%. In phase 2, the analysis of the intraclass correlation coefficient of AgNORs attributed to the system and human was 0.896 (95% confidence interval = 0.875-0.915; p < 0.0001), and this quantification with the CNN was 20 min compared to 67 h, considering human analysis. The AgNOR Slide-Image Examiner successfully differentiated the nuclei and accurately quantified the number of NORs in oral cytological smears. The cut-off risk point of 3.69 AgNOR/nucleus indicates a suspicious sample may contribute to improvements in oral cancer screening.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests: The authors certify that they have no commercial or associative interest that represents a conflict of interest in connection with the manuscript.

Figures

Figure 1
Figure 1. Scheme of cytopathological collection of oral mucosal smears and quantitative assessment of AgNOR in phase 1 by human manual quantification and in phase 2 by CNN quantification.
Figure 2
Figure 2. Cytosmear examples. Adequate samples for analysis: A) Cell containing 3 NORs/nucleus. B) Cell containing 5 NORs/nucleus. C) Cell containing 2 NORs/nucleus. Inadequate samples that were excluded from the study: D) Nuclear overlap and artifacts in the sample. E) Nucleus with poorly defined margin. F) Cell on the left: ill-defined cytoplasm. Cell on the right: nucleus without labeling for NORs. AgNOR. 1000×, oil immersion.
Figure 3
Figure 3. Quantification of NORs using the LabelMe system created by this group research (Ronnau et al.13) with segmentation using a bounding box. The bounding box technique was employed, digitally marking a rectangle with minimal dimensions to determine the nuclear area containing black dots corresponding to AgNORs. Demarcations were performed until reaching the first 50 cells well distended and not overlapping for posterior analysis by CNN. Cells bounding-boxed should present a clearly identified contour of the nuclear area. Nucleus overlapped or nuclear membrane presenting overlapping black dots were excluded. A: Bounding box around each selected nucleus. B: Identification of nuclei and NORs performed by the system.

Similar articles

Cited by

References

    1. Sarode G, Maniyar N, Sarode SC, Jafer M, Patil S, Awan KH. Epidemiologic aspects of oral cancer. Dis Mon. 2020 Dec;66(12):100988. doi: 10.1016/j.disamonth.2020.100988. - DOI - PubMed
    1. World Health Organization . World health report. Genebra: World Health Organization; 2002.
    1. Warnakulasuriya S, Kerr AR. Oral cancer screening: past, present, and future. J Dent Res. 2021 Nov;100(12):1313–1320. doi: 10.1177/00220345211014795. - DOI - PMC - PubMed
    1. Bezerra NV, Leite KL, Medeiros MM, Martins ML, Cardoso AM, Alves PM, et al. Impact of the anatomical location, alcoholism and smoking on the prevalence of advanced oral cancer in Brazil. Med Oral Patol Oral Cir Bucal. 2018 May;23(3):e295–e301. doi: 10.4317/medoral.22318. - DOI - PMC - PubMed
    1. Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003 Dec;39(8):770–780. doi: 10.1016/S1368-8375(03)00102-7. - DOI - PubMed

Substances